- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01914575
Dipole Density Mapping of Right and Left Atrial Supraventricular Tachycardia (DDRAMATIC-SVT)
January 29, 2019 updated by: Acutus Medical
Dipole Density Right (and Left) Atrial Mapping and Assessment of Therapy In Complex Supraventricular Tachycardia
Use of dipole density mapping to identify activation in complex supraventricular tachycardias
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Dublin, Ireland
- St. Vincent's University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- aged 18 to 75 years
- scheduled for ablation of atypical atrial flutter or paroxysmal atrial fibrillation
- able and willing to give informed consent
Exclusion Criteria:
- implanted prosthetic, artificial, or repaired cardiac valves in the chamber being mapped, permanent pacemaker or ICD leads in the chamber being mapped, and/or hypercoagulopathy or an inability to tolerate anticoagulation .
- myocardial infarction within the prior two months
- cardiac surgery within the prior three months
- intracardiac thrombus
- clinically significant tricuspid valve regurgitation or stenosis
- any cerebral ischemic event in the prior six months
- pregnant or nursing
- currently enrolled in any other clinical investigation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: DIAGNOSTIC
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Dipole Density Mapping
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The number of patients with device-related complications
Time Frame: 7 days
|
7 days
|
|
The number of patients for which activation maps can be created
Time Frame: 7 days
|
7 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: David Keane, MD, St. Vincent's University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ANTICIPATED)
January 22, 2014
Primary Completion (ACTUAL)
May 16, 2016
Study Completion (ACTUAL)
May 16, 2016
Study Registration Dates
First Submitted
July 31, 2013
First Submitted That Met QC Criteria
July 31, 2013
First Posted (ESTIMATE)
August 2, 2013
Study Record Updates
Last Update Posted (ACTUAL)
January 31, 2019
Last Update Submitted That Met QC Criteria
January 29, 2019
Last Verified
January 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CL-SVT-003
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Supraventricular Tachycardia
-
Erasmus Medical CenterUnknownTachycardia, Supraventricular | Tachycardia; Paroxysmal, SupraventricularNetherlands
-
Milestone Pharmaceuticals Inc.RecruitingParoxysmal Supraventricular TachycardiaUnited States, Spain, Canada, Germany
-
Milestone Pharmaceuticals Inc.IQVIA BiotechCompletedParoxysmal Supraventricular TachycardiaUnited States, Argentina, Brazil, Canada, Colombia
-
Tongji HospitalFirst Affiliated Hospital, Sun Yat-Sen University; Guangdong Provincial People... and other collaboratorsUnknownParoxysmal Supraventricular TachycardiaChina
-
Beijing Anzhen HospitalCompletedSupraventricular Tachycardia (SVT)China
-
Medtronic Cardiac Rhythm and Heart FailureMedtronicCompleted
-
Tehran University of Medical SciencesCompletedParoxysmal Supraventricular Tachycardia
-
Corxel PharmaceuticalsMilestone Pharmaceuticals Inc.CompletedTachycardia, Supraventricular | Paroxysmal Supraventricular TachycardiaChina
-
Yong Seog OhCompletedParoxysmal Supraventricular TachycardiaKorea, Republic of
-
Ruiqin xieCompletedParoxysmal Supraventricular TachycardiaChina
Clinical Trials on Mapping with the Acutus Medical System followed by Ablation
-
Acutus MedicalCompleted
-
Acutus MedicalCompleted
-
Acutus MedicalCompletedSupraventricular TachycardiaUnited Kingdom, Canada, Czechia, Belgium, Chile, Germany
-
Acutus MedicalCompleted
-
Hospital Clinic of BarcelonaCompleted
-
Medtronic Cardiac Ablation SolutionsCompletedAtrial Fibrillation | Ventricular Tachycardia | Atrial FlutterCzechia
-
Medtronic Cardiac Ablation SolutionsCompletedAtrial Fibrillation | Atrial FlutterLithuania
-
University of PittsburghMedtronicCompleted
-
Medtronic Cardiac Ablation SolutionsRecruitingVentricular Tachycardia (VT)United States
-
Asklepios proresearchAsklepios Klinik St. GeorgCompleted